Your browser doesn't support javascript.
Ligand-based Modeling of CXC Chemokine Receptor 4 and Identification of Inhibitors of Novel Chemotypes as Potential Leads towards New Anti- COVID-19 Treatments.
Daoud, Safa; Taha, Mutasem.
  • Daoud S; Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, Applied Sciences Private University, Amman, Jordan.
  • Taha M; Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, Jordan.
Med Chem ; 18(8): 871-883, 2022.
Article in English | MEDLINE | ID: covidwho-1631502
ABSTRACT

BACKGROUND:

Chemokines are involved in several human diseases and different stages of COVID-19 infection. They play a critical role in the pathophysiology of the associated acute respiratory disease syndrome, a major complication leading to death among COVID-19 patients. In particular, CXC chemokine receptor 4 (CXCR4) was found to be highly expressed in COVID-19 patients.

METHODS:

We herein describe a computational workflow based on combining pharmacophore modeling and QSAR analysis towards the discovery of novel CXCR4 inhibitors. Subsequent virtual screening identified two promising CXCR4 inhibitors from the National Cancer Institute (NCI) list of compounds. The most active hit showed in vitro IC50 value of 24.4 µM.

CONCLUSION:

These results proved the validity of the QSAR model and associated pharmacophore models as means to screen virtual databases for new CXCR4 inhibitors as leads for the development of new COVID-19 therapies.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, CXCR4 / Quantitative Structure-Activity Relationship / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Med Chem Journal subject: Chemistry Year: 2022 Document Type: Article Affiliation country: 1573406418666220118153541

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, CXCR4 / Quantitative Structure-Activity Relationship / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Med Chem Journal subject: Chemistry Year: 2022 Document Type: Article Affiliation country: 1573406418666220118153541